Recombinant interferon-α therapy for acute hepatitis B: A randomized, double-blind, placebo-controlled trial

Journal of Viral Hepatitis

Volumn 4, Issue 6, 1997, Pages 387-394

  Tassopoulos, N C ^a   Koutelou, M G ^a   Polychronaki, H ^a   Paraloglou Ioannides, M ^a   Hadziyannis, S J ^b  

^a Western Attica General Hospital   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Acute hepatitis B; Chronic hepatitis B; Interferon ; Serum HBV DNA

Indexed keywords

ALPHA2B INTERFERON; ANTIVIRUS AGENT; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ACUTE DISEASE; ADOLESCENT; ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FEMALE; HEPATITIS B; HUMAN; IMMUNOLOGY; LEUKOCYTE COUNT; LIVER FUNCTION TEST; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; INTERFERON ALFA-2B; LEUKOCYTE COUNT; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0031298553     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1997.00072.x     Document Type: Article

References (17)

1. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995; 13 (suppl): S47-S49.
2. Tassopoulos NC, Papaevangelou G, Sjogren MH, Roumeliotou-Karayiannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987; 92: 1844-1850.
3. Seeff LB, Beebe GW, Hoofnagle JH et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States army. N Engl J Med 1987; 316: 965-970.
4. Tassopoulos NC, Hadziyiannins SJ, Wright GE. A randomized double-blind, placebo-controlled trial of a-interferon in acute type B hepatitis. Hepatology 1989; 10: 576.
5. Chemello L, Mondelli M, Bortolotti M. Natural killer cell activity in patients with acute viral hepatitis. Clin Exp Immunol 1986; 64: 59-64.
6. Pignatelli M, Waters J, Level AML et al. HLA class I antigens on hepatocyte membrane: Increased expression during acute hepatitis and interferon therapy of chronic hepatitis B. Hepatology 1986; 6: 349-353.
7. Kuhns MC, McNamara AL, Cabal CM et al. A new assay for the quantitative detection of hepatitis B viral DNA in human serum. In: Zuckerman AJ, ed. Viral Hepatitis and Liver Disease. New York: Alan R. Liss, 1988: 258-262.
8. Trey C. The fulminant hepatic failure surveillance study; Brief review of the effects of presumed etiology and age on survival. Can Med Assoc J 1972; 106 (suppl): 525-527.
9. Redeker AG. Viral hepatitis: clinical aspects. Am J Med Sci 1975; 270: 9-16.
10. McMahon BJ, Alward WLM, Hall DB et al. Acute hepatitis B type infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599-603.
11. Levin S, Hahn T. Interferon system in acute viral hepatitis. Lancet 1982; i: 592-594.
12. Ikeda T, Lever AML, Thomas HC. Evidence for a deficiency of interferon alpha production in patients with chronic HBV infection acquired in adult life. Hepatology 1986; 6: 962-965.
13. Dudley FJ, Scheuer PJ, Sherlocks S. Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet 1972; ii: 1388-1393.
14. L-1,2,4-triazole-3-carboxamide in acute viral hepatitis. Ann NY Acad Sci 1977; 284: 278-283.
15. Lam KC, Lin HJ, Lai CL, Lam SK, Kwan YL. Isoprinosine in classical acute viral hepatitis. Am J Dig Dis 1978; 23: 893-896.
16. Blum AL, Berthet P, Doelle W et al. Treatment of acute viral hepatitis with (+)-cyanidanol-3. Lancet 1977; ii: 1153-1155.
17. Szmuness W, Much MI, Prince AM et al. On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med 1975; 83: 489-495.